Literature DB >> 9189221

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.

P J Goulder, A Edwards, R E Phillips, A J McMichael.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189221

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.

Authors:  D Durali; J Morvan; F Letourneur; D Schmitt; N Guegan; M Dalod; S Saragosti; D Sicard; J P Levy; E Gomard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif.

Authors:  M A Altfeld; B Livingston; N Reshamwala; P T Nguyen; M M Addo; A Shea; M Newman; J Fikes; J Sidney; P Wentworth; R Chesnut; R L Eldridge; E S Rosenberg; G K Robbins; C Brander; P E Sax; S Boswell; T Flynn; S Buchbinder; P J Goulder; B D Walker; A Sette; S A Kalams
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.

Authors:  R A Kaslow; C Rivers; J Tang; T J Bender; P A Goepfert; R El Habib; K Weinhold; M J Mulligan
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies.

Authors:  Donglai Liu; Chu Wang; Bhavna Hora; Tao Zuo; Nilu Goonetilleke; Michael K P Liu; Mark Berrong; Guido Ferrari; Andrew J McMichael; Tanmoy Bhattacharya; Alan S Perelson; Feng Gao
Journal:  Retrovirology       Date:  2017-10-10       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.